Michael McCormick
Surgical · Charlotte, NCNPI 1992951073
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,500 of the $1,848 with a category attached, or 81.2%. Intrinsic Therapeutics accounts for 81.2% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $1,549, more than ten times the $17 reported in 2021.
Across 21 payments — averaging $88.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intrinsic Therapeutics$2K
- Boston Scientific$112
- Johnson & Johnson$96
- Globus Medical$52
- Stryker$29
- Abbott$24
- plus $35 from 2 others
What the payments were for
- Consulting fees$1,50081%
- Food & beverage$34819%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intrinsic Therapeutics | 5 | $1,500 |
| Boston Scientific | 5 | $112 |
| Johnson & Johnson | 3 | $96 |
| Globus Medical | 3 | $52 |
| Stryker | 2 | $29 |
| Abbott | 1 | $24 |
| Acera Surgical, Inc. | 1 | $18 |
| Medtronic | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,848 in reported general payments places this provider in the 85th percentile of 248 surgical providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 147 | $1,260 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 84 | $899 |
| Tizanidine Hcl | 229 | $854 |
| Methocarbamol | 45 | $312 |
| Gabapentin | 19 | $268 |
| Dexamethasone | 12 | $192 |
| Methylprednisolone | 31 | $189 |
| Tramadol Hcl | 65 | $174 |
| Meloxicam | 54 | $171 |
| Levetiracetam | 17 | $149 |
| Oxycodone Hcl | 21 | $99 |
| Cyclobenzaprine Hcl | 25 | $96 |
| Diazepam | 17 | $19 |
Paid to pharmacies, not to this prescriber.
Other surgical in Charlotte
- Jennifer CokerCharlotte$2K
- Katherine DyerCharlotte$2K
- Justin BrooksCharlotte$2K
- Tina FiorettiCharlotte$2K
- Mackenzie SteenCharlotte$1K
- Brandon GriffinCharlotte$1K
- Kevan HaasChapel Hill$44K
- Lawrence LandriganWilmington$12K
- Erika LynchLeland$10K
- Sheila AndersonWilmington$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.